Allan B Okey

Author PubWeight™ 30.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 2004 4.10
2 Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries. Mol Pharmacol 2005 2.02
3 Unsupervised pattern recognition: an introduction to the whys and wherefores of clustering microarray data. Brief Bioinform 2005 1.64
4 Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2008 1.37
5 Regulating the regulator: factors that control levels and activity of the aryl hydrocarbon receptor. Biochem Pharmacol 2006 1.34
6 Transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in liver: comparison of rat and mouse. BMC Genomics 2008 1.18
7 Systematic evaluation of medium-throughput mRNA abundance platforms. RNA 2012 1.15
8 Evaluation of various housekeeping genes for their applicability for normalization of mRNA expression in dioxin-treated rats. Chem Biol Interact 2006 1.14
9 Polymorphisms in the human AH receptor. Chem Biol Interact 2002 1.11
10 Microarray analysis of the developing cortex. J Neurobiol 2006 1.11
11 microRNAs in adult rodent liver are refractory to dioxin treatment. Toxicol Sci 2007 1.07
12 Dioxin-responsive AHRE-II gene battery: identification by phylogenetic footprinting. Biochem Biophys Res Commun 2004 1.06
13 PUNS: transcriptomic- and genomic-in silico PCR for enhanced primer design. Bioinformatics 2004 0.99
14 Patterns of dioxin-altered mRNA expression in livers of dioxin-sensitive versus dioxin-resistant rats. Arch Toxicol 2008 0.93
15 Flavin-containing monooxygenase-3: induction by 3-methylcholanthrene and complex regulation by xenobiotic chemicals in hepatoma cells and mouse liver. Toxicol Appl Pharmacol 2010 0.91
16 Aryl hydrocarbon receptor-dependent induction of flavin-containing monooxygenase mRNAs in mouse liver. Drug Metab Dispos 2008 0.90
17 Aryl hydrocarbon receptor (AHR)-regulated transcriptomic changes in rats sensitive or resistant to major dioxin toxicities. BMC Genomics 2010 0.90
18 Hepatic transcriptomic responses to TCDD in dioxin-sensitive and dioxin-resistant rats during the onset of toxicity. Toxicol Appl Pharmacol 2011 0.88
19 Cross-species transcriptomic analysis elucidates constitutive aryl hydrocarbon receptor activity. BMC Genomics 2014 0.87
20 Differential expression profiling of the hepatic proteome in a rat model of dioxin resistance: correlation with genomic and transcriptomic analyses. Mol Cell Proteomics 2006 0.87
21 Genome-wide effects of acute progressive feed restriction in liver and white adipose tissue. Toxicol Appl Pharmacol 2008 0.85
22 Aryl hydrocarbon receptor splice variants in the dioxin-resistant rat: tissue expression and transactivational activity. Mol Pharmacol 2007 0.84
23 Inter-strain heterogeneity in rat hepatic transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Appl Pharmacol 2012 0.81
24 Advances in analytical techniques for polychlorinated dibenzo-p-dioxins, polychlorinated dibenzofurans and dioxin-like PCBs. Anal Bioanal Chem 2006 0.79
25 AH receptor antagonist inhibits constitutive CYP1A1 and CYP1B1 expression in rat BP8 cells. Biochem Biophys Res Commun 2004 0.79
26 mRNA levels in control rat liver display strain-specific, hereditary, and AHR-dependent components. PLoS One 2011 0.77
27 Gene expression profiling in a model of D-penicillamine-induced autoimmunity in the Brown Norway rat: predictive value of early signs of danger. Chem Res Toxicol 2005 0.76